EZH2 and urinary bladder cancer: Small molecule inhibitors of EZH2 (a H3K27 methyltransferase) have antimyeloma effects [22,24], and inhibitors of G9a (a H3K9 dimethyltransferase, also called EHMT2) have anticancer effects against urinary bladder cancer cells [25].